Anders Götzsche
Fortune : 59 904 $ au 30/06/2026
Fortune : 59 904 $ au 30/06/2026
Anders Gtzsche est président de Rosborg Mbler An et directeur financier et vice-président exécutif de H. Lundbeck A. Il est également membre du conseil d'administration de DFDS An et d'Obsidian Therapeutics, Inc. Il a précédemment occupé le poste de directeur financier chez Berlingske Media A, de directeur des ventes chez SAS Institute SAS et de directeur de la comptabilité et des rapports chez Group 4 Falck A. M. Gtzsche a obtenu un diplôme d'études supérieures de l'Université du Danemark du Sud.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
DFDS A/S 0,01 % | 19/02/2026 | 3 500 ( 0,01 % ) | 59 904 $ | 30/06/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| DFDS A/S | Directeur/Membre du Conseil | 19/03/2018 |
Rosborg Møbler A/S
Rosborg Møbler A/S Internet RetailRetail Trade Operates chairs, tables, sofas, shelves and sideboards stores through an online | Président | 23/06/1999 |
Obsidian Therapeutics, Inc.
Obsidian Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops TIL cell therapies for the treatment of patients with solid tumors | Directeur/Membre du Conseil | 01/03/2020 |
Velux A/S
Velux A/S Forest ProductsNon-Energy Minerals Manufactures construction and building materials such as roof windows and skylights | Directeur Financier/CFO | - |
| Sociétés | Poste | Fin |
|---|---|---|
| H. LUNDBECK A/S | Directeur Général | 31/08/2018 |
Berlingske Media A/S
Berlingske Media A/S Advertising/Marketing ServicesCommercial Services Operates as a media group | Directeur Financier/CFO | 01/08/2007 |
Group 4 Falck A/S
Group 4 Falck A/S Miscellaneous Commercial ServicesCommercial Services Provides security services | Comptroller/Controller/Auditor | 01/03/2005 |
SAS Institute SAS
SAS Institute SAS Packaged SoftwareTechnology Services Provides business intelligence and analytics software solutions | Sales & Marketing | 01/01/2001 |
OL Holding ApS
OL Holding ApS Financial ConglomeratesFinance Functions as an investment holding company | Directeur/Membre du Conseil | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 11 |
|---|---|
Group 4 Falck A/S
Group 4 Falck A/S Miscellaneous Commercial ServicesCommercial Services Provides security services | Commercial Services |
H. Lundbeck A/S
H. Lundbeck A/S Pharmaceuticals: MajorHealth Technology Engages in the research, development, production and sale of pharmaceuticals for the treatment of brain diseases | Health Technology |
Veloxis Pharmaceuticals A/S
Veloxis Pharmaceuticals A/S Pharmaceuticals: MajorHealth Technology Develops and commercializes medicines for the prevention of organ rejection in kidney transplant patients | Health Technology |
DFDS A/S
DFDS A/S Marine ShippingTransportation Provides shipping and transport services | Transportation |
Berlingske Media A/S
Berlingske Media A/S Advertising/Marketing ServicesCommercial Services Operates as a media group | Commercial Services |
University of Southern Denmark
University of Southern Denmark Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
SAS Institute SAS
SAS Institute SAS Packaged SoftwareTechnology Services Provides business intelligence and analytics software solutions | Technology Services |
OL Holding ApS
OL Holding ApS Financial ConglomeratesFinance Functions as an investment holding company | Finance |
Velux A/S
Velux A/S Forest ProductsNon-Energy Minerals Manufactures construction and building materials such as roof windows and skylights | Non-Energy Minerals |
Rosborg Møbler A/S
Rosborg Møbler A/S Internet RetailRetail Trade Operates chairs, tables, sofas, shelves and sideboards stores through an online | Retail Trade |
Obsidian Therapeutics, Inc.
Obsidian Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops TIL cell therapies for the treatment of patients with solid tumors | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national